SUSAN STANFORTH: Open Payments
NPI 1861972689 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 21 payments from 11 companies in 2025. Trend: 2023 $1,180 · 2024 $559 · 2025 $487
Food & beverage: $445Education: $42
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 3 | $86 |
| ABBVIE INC. | 4 | $84 |
| PFIZER INC. | 4 | $77 |
| Daiichi Sankyo Inc. | 2 | $57 |
| SANOFI-AVENTIS U.S. LLC | 1 | $42 |
| Boston Scientific Corporation | 1 | $33 |
| Celgene Corporation | 2 | $28 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: Yescarta, EPKINLY, Enhertu, ELREXFIO, SARCLISA, Padcev, General - Pain Management, REBLOZYL.
Industry payments across NY — which companies pay providers there.
